Summary: Avadel Pharmaceuticals announced its second-quarter results, highlighting the progress of its narcolepsy drug, Lumryz. The company initiated a phase 3 trial for Lumryz in idiopathic hypersomnia and awaits an FDA decision on its use in pediatric narcolepsy. Lumryz, … [Read more...]
BRPT Announces Winner of A-STEP/STAR Educational Grant
Summary: The Board of Registered Polysomnographic Technologists (BRPT) announced Griselda Molina from Westminster, Colo, as the winner of its A-STEP/STAR Educational Grant Program. Chosen from over 40 applications across 23 states and several countries, Molina, with a decade of … [Read more...]
Genio Neurostimulator Maker Gears Up for Anticipated US Market Entry
Summary: Nyxoah SA, the maker of the CE-marked Genio neurostimulator system for obstructive sleep apnea, reported its financial and operational results for the second quarter and first half of 2024. The company has completed its FDA regulatory submission for Genio and expects a … [Read more...]
OrthoApnea NOA Reaches 450,000 Users Following FDA Approval
Summary: The OrthoApnea NOA, a 3D-printed nylon oral appliance approved by the FDA in 2021, has been utilized by over 450,000 patients for the treatment of mild to moderate obstructive sleep apnea (OSA) and snoring. Developed through a collaborative effort among biomedical … [Read more...]
Sleep Could Unlock New Treatment Window for PTSD
Summary: A new study shows that reactivating therapeutically altered memories during sleep can enhance brain activity related to memory processing, potentially reducing PTSD symptoms. The research suggests that incorporating targeted memory reactivation (TMR) during sleep, … [Read more...]
Smart Earbuds Detect Drowsiness to Prevent Workplace Accidents
Summary: UC Berkeley researchers have developed smart earbuds capable of detecting brain activity linked to drowsiness, potentially preventing workplace accidents among drivers and machine operators. These earbuds function similarly to an EEG, using built-in electrodes to monitor … [Read more...]
Inspire Expands Reach with New Approvals
Summary: Inspire Medical Systems Inc reported its second-quarter 2024 business and operational results, highlighting several key achievements. These include receiving FDA approval for the Inspire V neurostimulation system, CE Mark certification under EU MDR, and securing … [Read more...]
Slide2Sleep’s Nylon Oral Appliance Offers More Strength, Comfort
Summary: Slide2Sleep released a nylon version of its Slide oral appliance in June 2023, offering increased strength and a slimmer profile compared to the acrylic model. This new model, crafted from type 12 nylon and 3D printed using selective laser sintering technology, addresses … [Read more...]
Harmony Advances Pitolisant High-Dose Development Program
Summary: Harmony Biosciences reported strong second-quarter results and advancements in its pitolisant high-dose (HD) development program, aiming for a PDUFA date in 2028. The company highlighted revenue growth driven by Wakix and continued progress across its sleep/wake disorder … [Read more...]
Lucid Dreaming Research Lab Launches in Silicon Valley
Summary: Lucid dreaming researchers at the startup REMspace Inc have opened a laboratory in Redwood City, Calif, with the goal of developing technologies to explore lucid dreams, sleep paralysis, and other REM sleep phenomena. The team has previously demonstrated the ability to … [Read more...]
- « Previous Page
- 1
- …
- 26
- 27
- 28
- 29
- 30
- …
- 77
- Next Page »